API Product   :    Rupatadine Fumarate
CEP   :    -
WCC   :    -
Therapeutic Use    :    Systemic Antihistamines; Anti-asthma and COPD Products
Systemic Antihistamines; Anti-asthma and COPD Products
Originator   :    Pediapharm
CAS No.    :    158876-82-5
Trade Name.   :    Rupafin
Molecular Weight   :    415.958 g/mol
Molecular Formula   :    C26H26ClN3
Rupatadine fumarate has been approved for the treatment of allergic rhinitis and chronic urticaria in adults and children over 12 years. It is available as round, light salmon coloured tablets containing 10 mg of rupatadine (as fumarate) to be administered orally, once a day.
Rupatadine is a second generation antihistamine and PAF antagonist used to treat allergies. It was discovered and developed by J. Uriach y Cia and is marketed as Rupafin and under several other trade names.